EN DE
STOCK COMPARISON

Solutiance vs Contemporary Amperex Technology Co., Limite: Fair Value & Quality

Both stocks run through our valuation models. Here is how Solutiance (SLSA) and Contemporary Amperex Technology Co., Limite (3750) compare, as of Aug 10, 2026.

As of Aug 10, 2026, Fair Value Calculator sees Contemporary Amperex Technology Co., Limite as the less overvalued of the two: Solutiance trades at €1.14 versus a fair value of €0.45 (-61%), while Contemporary Amperex Technology Co., Limite trades at HK$641 versus HK$391 (-39%).
Solutiance
SLSA.XETRA · EUR · Health Care
-61%
upside to fair value
overvalued
Price€1.14
Fair Value€0.45
Quality60/100
Contemporary Amperex Technology Co., Limite
3750.HK · HKD · Industrials
-39%
upside to fair value
overvalued
PriceHK$641
Fair ValueHK$391
Quality64/100

Head-to-head numbers

Green value = the better side for that row (for valuation multiples: lower = cheaper).

SolutianceContemporary Amperex Technology Co., Limite
Valuation
53.5×P/E (TTM)33.7×
1.21×P/S (TTM)6.73×
P/B9.35×
EV/EBITDA26.0×
PEG2.29×
Profitability
2%Net margin17%
-0%Operating margin19%
Return on equity25%
-1%Return on assets5%
Growth
0%Revenue growth (YoY)52%
32.4%Avg. growth/yr (3Y)8.8%
28.5%Avg. growth/yr (5Y)53.1%
Balance & size
Debt / equity0.24×
$8MMarket cap$402B
mixedGrowth qualityhealthy

Contemporary Amperex Technology Co., Limite leads: 2 to 6 metric wins.

Dash = not meaningfully computable, for example with negative equity.

Quality in detail

The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.

Solutianceof which business quality 60 · market factors 32 Contemporary Amperex Technology Co., Limiteof which business quality 65 · market factors 71
ProfitabilityMargins and returns on capital today
64
49
Quality GrowthAre margins and returns improving?
69
63
CashflowEarnings quality: real cash, not paper profit
79
83
Fin. StrengthBalance sheet, leverage, solvency risk
22
86
InvestmentDisciplined investing over empire-building
100
23
Low VolatilityCalm price path (market factor)
85
66
MomentumPrice trend over the last 3–12 months (market factor)
12
69
52W MomentumDistance to the 52-week high (market factor)
8
79
Net IssuanceBuybacks instead of dilution
45
64

What the models say

The median fair value (base case) per model family, each in the currency of its trading venue. Green = above the current price, red = below.

Solutiance

DCF Models€1.35
Earnings-Based€0.36
Multiples€0.50
Growth DCF€1.78
Economic Profit€0.28
Growth Earnings€0.53

12 of 21 models see the stock below the current price.

Contemporary Amperex Technology Co., Limite

DCF ModelsHK$600
Earnings-BasedHK$565
Dividend DiscountHK$139
MultiplesHK$307
Asset-BasedHK$50.49
Growth DCFHK$591
Economic ProfitHK$239
Growth EarningsHK$739

19 of 26 models see the stock below the current price.

Scenario ranges

From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.

Solutiance
Bear €0.36Fair Value €0.45Bull €0.60
€1.14 = current price (white tick)
Contemporary Amperex Technology Co., Limite
Bear HK$294Fair Value HK$391Bull HK$957
HK$641 = current price (white tick)

Compare two other stocks

Tap a field and type again, ticker or company name.

Free, no sign-up

Ranked within their sector

Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.

Solutiance · Health Care

Quality score60 · above median
Fair value upside-61% · below median

Contemporary Amperex Technology Co., Limite · Industrials

Quality score64 · Top 25%
Fair value upside-39% · below median

Bottom line

As of Aug 10, 2026, Fair Value Calculator sees Contemporary Amperex Technology Co., Limite as the less overvalued of the two: Solutiance trades at €1.14 versus a fair value of €0.45 (-61%), while Contemporary Amperex Technology Co., Limite trades at HK$641 versus HK$391 (-39%).

Contemporary Amperex Technology Co., Limite has the higher quality score (64/100).

See the full analysis →

More comparisons

Popular match-ups from the same sectors, all with fair value and quality score.

Free · Top-25 report

See the undervalued quality stocks every month

Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.

A model-based valuation snapshot from 21 models. Values change with price and fundamentals; the date shown above applies.